Search

Primary Acquired Nasolacrimal Duct Obstruction (PANDO) PANDO is a condition in which chronic inflammation and scarring block the tear drainage system without another identifiable cause for the obstruction, such as trauma, tumor, etc. Patients with PANDO usually seek help when tears overflow...

In this issue of eye Insights, we take a close look at idiopathic intracranial hypertension (IIH). You'll find key information about how IIH is diagnosed and treated. Inside: Message from the Editor-in-Chief What is Idiopathic Intracranial Hypertension? How is a Patient Diagnosed? What are the...

Dear Colleagues, In this issue of eye Insights, we take a close look at idiopathic intracranial hypertension (IIH). Inside, you’ll find key information about how IIH is diagnosed and treated as well as further reading. IIH is becoming more prevalent due to increasing rates of obesity in the United...

Acetazolamide The first-line medical therapy is acetazolamide, which reduces CSF production by the choroid plexus. In the recent IIH Treatment Trial, acetazolamide, in addition to weight loss, was found to be more effective than weight loss alone in patients with IIH and mild visual loss. The...

Nearly half of Americans who currently have glaucoma are unaware of their condition. Why? Most types of glaucoma are painless, with no feelings of discomfort. Glaucoma typically affects peripheral vision first, so many people remain unaware of the disease until their central vision is affected...

The Problem You are doing all you can do, surgically and medically, for your patients with vision impairment, but they continue to report difficulty with visual tasks or have to abandon activities they enjoy. The Solution Vision rehabilitation is the next step in the continuum of ophthalmic care...

Diagnosis As part of a thorough history, it’s important to ask about the use of medications associated with OIS, such as bisphosphonates taken for the treatment of osteoporosis. A comprehensive ophthalmic evaluation is performed. Pain can be an important symptom of OIS, particularly in myositis and...

Applications are due February 25, 2022Contact Kahira Saez This postdoctoral program, sponsored by the National Eye Institute, provides expert training in molecular approaches and techniques that can be applied to ophthalmology and vision research. In includes full-time research, didactic courses...

The year 2020 holds special significance for ophthalmologists—it’s a reminder that in our ideal world, everyone everywhere would have 20/20 vision. In honor of this momentous year, Harvard Ophthalmology is launching 2020 Vision—A World Without Blindness. This year-long initiative celebrates our...

Multidisciplinary Collaboration Accelerates Finding Cures Our research is focused on eliminating blinding diseases and disorders of the eye and visual system. Tackling these conditions with a multifaceted, multidisciplinary approach has been the mainstay of our past success in translational medicine...